A national population-based case-control study was conducted in New Zealand to assess the effects of hormonal contraception on breast-cancer risk. A total of 891 Women aged 25 to 54 with a first diagnosis of breast cancer, and 1864 control subjects, randomly selected from the electoral rolls, were i
Risk of breast cancer associated with short-term use of oral contraceptives
β Scribed by Suzanne G. Folger; Polly A. Marchbanks; Jill A. McDonald; Leslie Bernstein; Giske Ursin; Jesse A. Berlin; Janet R. Daling; Sandra A. Norman; Brian L. Strom; Linda K. Weiss; Michael S. Simon; Ronald T. Burkman; Kathleen E. Malone; Robert Spirtas
- Publisher
- Springer Netherlands
- Year
- 2007
- Tongue
- English
- Weight
- 152 KB
- Volume
- 18
- Category
- Article
- ISSN
- 0957-5243
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
One hundred and seventy four (81% of all) pathologically confirmed new incident cases of female breast cancer identified from a medical center in Taipei from February, 1993 to June, 1994 were selected as the case group. Four hundred and fifty three inpatient controls who were without obstetricgyneco
To evaluate the relationship between use of oral contraceptives and risk of invasive cervical cancer, a case-control study involving 479 patients and 789 population controls was undertaken in 5 geographic regions of the US. Initially, the relationship was obscured by confounding variables, particula
We examined the association between oral contraceptive use and risk of specific breast cancer histopathologies in a large, multi-center, population-based, case-control study. Women younger than age 75 with a new diagnosis of invasive breast cancer were identified from 4 statewide tumor registries. W
## Abstract Several epidemiologic studies have reported a protective effect of oral contraceptives (OCs) on ovarian cancer. However, there remain open issues, including better quantification of timeβrelated factors such as time since last use, age at first use and time since first use. We performed